Australia's most trusted
source of pharma news
Posted 3 August 2022 AM
A new industry-led group focused on advancing cell and gene therapies in Australia is on the hunt for a general manager.
Dubbed 'Australia's Cell and Gene Catalyst', the new group is a joint venture between peak industry bodies AusBiotech and Medicines Australia (MA) which are part of the Steering Group along with CSL Behring, Novartis, Pfizer, Therapeutic Innovation Australia and Cell Therapies.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.